Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with Bioabsorbable Polymer and Everolimus Drug Coating

Source :: Clinical Trials Week. August 16, 2010, 11
Publication Year :: 2010
Abstract: Boston Scientific Corporation (NYSE:BSX) announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. [...]

Subjects :: Boston Scientific Corp. -- Product development
Stent (Surgery) -- Product development
Medical test kit industry -- Product development
Medical equipment and supplies industry -- Product development
Clinical trials
Angiogenesis inhibitors
Health

Tools